PSYCHEDELIC MEDICINE, HERE AND NOW
A growing network of psychiatry clinics, research sites and therapeutic retreats specialized in psychedelic medicine
Chief Executive Officer, Director, Co-Founder
Yaron Conforti is an entrepreneur and the principal of EmmCap Corp., an investor in venture-stage companies. EmmCap actively participates in its early-stage investments via board and management roles. Yaron has over 20 years of venture capital investing and operating experience, including founder and CEO roles in companies across different industries. Past EmmCap investments include Abacus Health Products (acquired by Charlotte’s Web), GR Silver Mining Ltd. (TSXV:GRSL) and IM Cannabis Corp. (CSE:IMCC). Yaron previously served in senior investment banking roles at Desjardins Securities and Sandfire Securities where he focused on micro/small cap equities.
Senior Vice President, Head of M&A
Joseph has gained tenure as a M&A specialist and strategist, building sustainable programmatic M&A approaches for high-growth organizations. Leveraging over 20 years of professional experience, Joseph recently led the M&A group as Vice President, Business and Corporate Development at Canadian Addiction Treatment Centres (CATC), a consolidator of outpatient addiction treatment clinics that currently operates over 70 clinics and an inpatient residential treatment facility. Joseph previously held senior M&A roles at People Corp. (acquired by Goldman Sachs Merchant Banking), Rexall Health Solutions (a subsidiary of McKesson Corp.) and Deloitte.
Pierre Bou-Mansour, P.Eng.
Chief Operating Officer
An accomplished senior executive and leader, Pierre brings a wealth of experience managing large and complex healthcare organizations. Most recently, he served as the Chief Laboratory Operations Officer of Public Health Ontario, serving Canada's largest province with over 14 million residents. In this role, Bou-Mansour successfully led the expansion of Public Health Ontario's testing capacity for the COVID-19 response.
Pierre has a proven track record for growing and transforming healthcare companies. He spent eight years at LifeLabs, serving as the COO from 2017 to 2019, and successfully led the integration of two acquired competitors. During this period, LifeLabs grew into one of the largest medical service companies in Canada, with over 5,700 employees, 370 patient access sites, and over US $977 million in annualized revenue (dnb.com).
Reid Robison, MD, MBA
Chief Medical Officer, Director
Dr. Reid Robison is a board-certified psychiatrist who was named Best Psychiatrist in Utah by Salt Lake City Weekly’s Best of Utah Body & Mind 2020. Dr. Robison is the co-founder of Cedar Psychiatry and serves as the Medical Director for the Center for Change, a leading Eating Disorder center. He is currently the coordinating investigator for the MAPS-sponsored MDMA-assisted psychotherapy study of eating disorders. As an early adopter and researcher of ketamine in psychiatry, Dr. Robison led a pivotal IV ketamine study for treatment-resistant depression by Janssen, leading up to the company’s recent FDA-approval of Spravato™. To date, Dr. Robison has guided thousands of ketamine therapy journeys and hundreds of Spravato™ dosing sessions. As a social entrepreneur, Dr. Robison has built a number of purpose-driven companies including Tute Genomics which was acquired by PierianDx in 2016. Dr. Robison is also an adjunct professor at both the University of Utah and Brigham Young University and is the founder of the Polizzi Free Clinic, a free mental health clinic for marginalized people based in Salt Lake City, Utah.
Seneca Anderson began her career in business process redesign and engineering in higher education, including with New York University, Pepperdine University and the California State University system. In addition to analyzing business flow to identify process gaps and maximize efficiencies, Seneca met with stakeholders to unify and execute their vision. After seventeen years in higher education, she transitioned her skills to building best in class behavioral health clinics in the United States. She is most well-known for maximizing set-up and design, and negotiating with insurance companies to maximize clinic reimbursement, while offering timely outpatient mental health care, including TMS, Spravato™ and ketamine-assisted psychotherapy.
Prakash Gowd, MBA, BSc Pharm, C Dir
SVP, Corporate Development
Prakash brings 25 years of experience in capital markets, biopharma and health sciences. He is Co-Founder and Advisor at Lobo Genetics, previously held senior healthcare equity research roles at CIBC, Canaccord Capital and National Bank Financial, was a consultant to life science companies, and helped guide new product planning and commercial development at GlaxoSmithKline. He also served as Audit Chair and board director of a public drug development company. Prakash holds an MBA from McGill University, a BSc Pharmacy from the University of British Columbia, and a Chartered Director designation.
VP, Business Development
Prior to Novamind, Nolan was an analyst at First Republic Capital, a Canadian investment bank, where he financed early-stage growth companies with debt and equity private placements. In 2017 he graduated from Dalhousie University where he majored in finance and earned a Bachelor of Commerce. Nolan is a level III candidate in the CFA program.
Board of directors
Jesse Kaplan, CFA
Jesse Kaplan has been a partner with Plaza Capital Limited since 2015. His career has focused on advising and investing in early stage growth companies. This has included extensive work helping companies through the process of going public in both Canada and the United States. Jesse was previously a senior analyst at Harborview Advisors LLC, a New York based investment firm and Palladium Capital Advisors, LLC, a NASD member investment bank. Currently, he is a board member of Abacus Health Products (CSE:ABCS) among other successful companies.
Sruli Weinreb is the founder and managing partner of Plaza Capital Limited. Plaza Capital supports many North American early stage growth companies with strategic debt placements and equity investments. He is also the chief executive officer of Lake Central Air Services Inc., the world’s leading modification and integration partner for the airborne geophysical survey industry. Before founding Plaza Capital in 2013, Sruli was the chief executive officer of eMobile Inc., a telecom arbitrage company with a specialization in international roaming which he co-founded in 2008.
Chuck Rifici, CPA, MBA
Chuck is a pioneer of the North American cannabis industry, having created and managed opportunities which have had an incredible and widespread impact on the Canadian cannabis landscape. The founder of Canopy Growth (FKA Tweed Marijuana), Chuck is a chartered professional accountant (CPA). He obtained his MBA from Queen’s University and holds a BASc in Computer Engineering from the University of Ottawa.